Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 Modulation
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c13156 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Dong Kwang Min und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Colitis, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
- Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
- Department of MetaBioHealth, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
- Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
- Institute of Quantum Biophysics (IQB), Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
ORCID-Profile: Jaeyun Kim
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Min, D. K., Mo, X. W., & Kim, J. (2025). Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 Modulation. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c13156
Vancouver
Min DK, Mo XW, Kim J. Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 Modulation. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c13156
BibTeX
@article{Min2025,
author = {Min, Dong Kwang and Mo, Xin Wang and Kim, Jaeyun},
title = {Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 Modulation},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c13156}
}
EUVIMED